Teva, Mylan Back Plan For New Bellwether In Price-Fix MDL

By Nadia Dreid · March 2, 2021, 6:53 PM EST

Mylan, Teva and Par Pharmaceuticals are among a group of generic-drug makers that told a Pennsylvania federal judge Monday they're fine with her plan to swap out a bellwether case in...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login